Home>Topics>Companies>Mead Johnson & Company

Mead Johnson & Company

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
  1. Mead Johnson Nutrition declares $0.375 dividend

    Headlines

    Thu, 4 Sep 2014

    Mead Johnson Nutrition (NYSE: MJN ) declares $0.375/share quarterly dividend , in line with previous. Forward yield 1.60% Payable Oct. 1; for shareholders of record Sept. 15; ex-div Sept. 11. Post your comment!

  2. New Morningstar Analyst Report for Mead Johnson Nutrition Co

    Stock Reports

    Mon, 4 Aug 2014

    Despite Mead Johnson 's competitive ..... Around 70% of Mead Johnson 's sales ..... recommending Mead Johnson 's branded ..... value since Mead Johnson began operating ..... entity. Stephen Golsby , who was ..... result. Mead Johnson Nutrition is a supplier ..... with its Enfamil brand as

  3. Mead Johnson ’s 2Q Results Reflect Healthy Volume Growth; Narrow Moat Remains Intact

    Commentary

    Tue, 22 Jul 2014

    Mead Johnson reported solid second ..... contributing 5%) suggests that Mead Johnson ’s advertising and promotion efforts are strengthening Enfamil ’s brand equity, and we ..... the long term, we think Mead Johnson can leverage its brand equity

  4. PJP PowerShares Dynamic Pharmaceuticals ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Mon, 5 May 2014

    diagnostics division, point-of-care diagnostics division), Pfizer (Zoetis ZTS), and Bristol-Myers Squibb BMY ( Mead Johnson MJN ). Other deals have been due to cost-cutting potential or firms exiting areas where they lacked critical mass

  5. IHE iShares US Pharmaceuticals ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Mon, 5 May 2014

    diagnostics division, point-of-care diagnostics division), Pfizer (Zoetis ZTS), and Bristol-Myers Squibb BMY ( Mead Johnson MJN ). Other deals have been due to cost-cutting potential or firms exiting areas where they lacked critical mass

  6. XPH SPDR S&P Pharmaceuticals ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Mon, 5 May 2014

    diagnostics division, point-of-care diagnostics division), Pfizer (Zoetis ZTS), and Bristol-Myers Squibb BMY ( Mead Johnson MJN ). Other deals have been due to cost-cutting potential or firms exiting areas where they lacked critical mass

  7. Mead Johnson Faces a Number of Headwinds, but Moat Remains Intact; Shares Undervalued

    Commentary

    Fri, 31 Jan 2014

    Mead Johnson reported fourth ..... and we think Mead Johnson should remain on ..... radars. We think Mead Johnson 's business economics ..... strong narrow moat. Mead Johnson generates some ..... advantages gained from Enfamil 's brand equity

  8. China’s Bitter Medicine for Foreign Drug Companies

    Headlines

    Tue, 1 Oct 2013

    in fines on six manufacturers of powdered infant formula, including Illinois producers Abbott Laboratories and Mead Johnson Nutrition , for “various forms of resale price maintenance” that the commission said violated China’s Anti-Monopoly

  9. Mead Johnson Shares Pop as Firm Maintains Fiscal 2013 Guidance, Despite Price Decreases in China

    Commentary

    Thu, 25 Jul 2013

    Mead Johnson MJN reported second-quarter results ..... cash generated since our last update. Mead Johnson 's shares popped around 10% in early ..... we maintain a very positive view on Mead Johnson , its shares now trade at a modest premium

  10. Mead Johnson Lowering Prices on Some China Products by 7%-15%; Maintaining Fair Value Estimate

    Commentary

    Wed, 10 Jul 2013

    Mead Johnson MJN has announced its intentions to decrease ..... suppliers for price fixing in the region. Mead Johnson ’s lower prices will be reflected on ..... reinforcements will be an important part of Mead Johnson ’s strategy to retain consumers’ trust

« Prev12345Next »
Content Partners